Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1999
11/17/1999CN1046531C Metal complex and conjugated articles with electric coupling radicals, use and preparation thereof
11/16/1999US5986177 Bacillus thuringiensis isolates with broad spectrum activity
11/16/1999US5986176 Isolated antimicrobial protein having amino acid sequencecontaining common cysteine/glycine domain of chitin bindingplant proteins; agicultural and pharmaceutical applications as fungicides or bacetricides
11/16/1999US5986174 Maize promoter sequence for leaf- and stalk-preferred gene expression
11/16/1999US5986171 Method for examining neurovirulence of polio virus
11/16/1999US5986082 Altered forms of the NIM1 gene conferring disease resistance in plants
11/16/1999US5986081 Polynucleotides encoding herg-3
11/16/1999US5986079 Expression of pace in host cells and methods of use thereof
11/16/1999US5986078 DNA sequence encoding the tumor suppressor gene ING1
11/16/1999US5986073 Acidification and precipitation of somatotropins
11/16/1999US5986072 Coupling to glycidyl methacrylate-styrene copolymer through spacers
11/16/1999US5986070 Nerve growth factor expressed in prokayotic cells with proteins
11/16/1999US5986069 Human haemopoietic maturation factor polypeptides
11/16/1999US5986068 Luetinizing hormone, follicle stimulating hormone, thyroid stimulating hhormone and chronic gonadotropin linked with oligosaccharide
11/16/1999US5986067 Mutants of transferrins
11/16/1999US5986064 Antibodies which specifically bind to human tumor-associated Kazal inhibitor-like polypeptide
11/16/1999US5986063 Isolating β-lactoglobulin and α-lactalbumin by eluting from a cation exchanger without sodium chloride
11/16/1999US5986062 Polysaccharides, albumin and proteins
11/16/1999US5986061 Phosphorylated fusion proteins
11/16/1999US5986060 Polypeptide with amino acid sequences
11/16/1999US5986059 T-cell selective interleukin-4 agonists
11/16/1999US5986058 Growth differentiation factor with amino acid sequences
11/16/1999US5986057 Amino acid sequences
11/16/1999US5986056 Chordin compositions
11/16/1999US5986055 CDK2 interactions
11/16/1999US5986054 Genetic sequences and proteins related to alzheimer's disease
11/16/1999US5986053 Peptide nucleic acids complexes of two peptide nucleic acid strands and one nucleic acid strand
11/16/1999US5986052 Fusion polypeptide containing fragments of cartilage matrix protein and link protein
11/16/1999US5986051 Genes of Helicobacter pylori necessary for the regulation and maturation of urease and their use
11/16/1999US5986050 Soy protein dispersion and peracylation
11/16/1999US5986049 Purification by applying a biological fluid to polypeptide support,washing, elution, fractionation and accumulation
11/16/1999US5986048 Process for obtaining insulin precursors having correctly bonded cystine bridges
11/16/1999US5986047 Peptides that bind to the erythropoietin receptor
11/16/1999US5985857 Generating stable protein-sugar post-amadori advanced glycation end-product (age) intermediates comprising incubating protein with pentose sugar
11/16/1999US5985846 Gene therapy for muscular dystrophy
11/16/1999US5985840 Surfactants formed from menhaden fish
11/16/1999US5985833 Thrombin inhibitor
11/16/1999US5985832 Inhibiting osteoclastogenesis by administering osteoclast inhibitor protein (oip) to a cell
11/16/1999US5985831 Methods for controlling lepidopterans using Bacillus thuringiensis toxins obtainable from isolates PS17, PS86Q3, and HD511
11/16/1999US5985829 Screening assays for compounds that cause apoptosis and related compounds
11/16/1999US5985828 Screening for agonists and antagonists of the receptor ligands, for producing diagnostic or therapeutic reagents, and for producing antibodies
11/16/1999US5985827 Increasing the specificity of a synthetic arg-gly-asp-containing ligand for an arg-gly-asp receptor comprising conformationally restricting the arg-gly-asp sequence by forming a cyclic peptide
11/16/1999US5985825 Methods and compositions for optimization of oxygen transport by cell-free systems
11/16/1999US5985822 Relates to peptides comprising at least part of the amino acid sequence of neural cell adhesion molecule (n-cam) and to compositions that utilize these peptides to inhibit dna synthesis and cell division of glial cells
11/16/1999US5985657 Nucleotide sequence coding for human il-1; expression vectors and host cells
11/16/1999US5985656 Human cell line comprising, double negative suppressor cells characterized by specific surface marker pattern, which inhibit the mixed lymphocyte reaction in vitro, but do not kill corresponding target cells; density gradient separation
11/16/1999US5985655 Retroviral vector particle containing a chimeric envelope includes a receptor binding region that binds to a receptor of a target cell; a portion of the envelope gene deleted and replaced with another receptor binding region or ligand
11/16/1999US5985654 Gene which expresses a protein corresponding to the conserved exposed region of the m6 protein, a virulence factor of streptococcus; poxvirus such as vaccinia containing m6 gene used as vaccines against streptococcal infection
11/16/1999US5985643 Mutant antibiotic resistant staphylococcus aureus strain with increased sensitivity to antibiotics to which parent strain was resistant, with known mutation insertion site, and with blockade of cell wall synthesis; for reversing resistance
11/16/1999US5985641 Non-infectious, replication-impaired, immunogenic human immunodeficiency virus type 1 retrovirus-like particles with multiple genetic deficiencies
11/16/1999US5985634 Chloroplast activity
11/16/1999US5985631 Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease
11/16/1999US5985616 Chimeric mammalian NPY Y5 receptors
11/16/1999US5985614 Polynucleotides encoding interleukin-19
11/16/1999US5985613 Use of an "immunodeficiency-virus suppressing lymphokine (ISL) "to inhibit the replication of viruses, in particular of retroviruses
11/16/1999US5985611 Culturing animal cells; transformation with gene expression; recovering
11/16/1999US5985610 Gene expression in host cell of conformational epitopes
11/16/1999US5985609 Process for preparing hepatitis C virus envelope glycoproteins
11/16/1999US5985608 Actin-binding polypeptides and nucleic acids encoding the same
11/16/1999US5985607 Gene expression control sequence
11/16/1999US5985606 Human preprotachykinin B
11/16/1999US5985604 Polynucleotide
11/16/1999US5985603 P2x receptor DNA and protein sequence
11/16/1999US5985602 Secreted proteins and polynucleotides encoding them
11/16/1999US5985601 Isolated polynucleotide
11/16/1999US5985600 Nucleic acid encoding delta opioid receptor
11/16/1999US5985599 Nucleic acid encoding a protein capable of binding to immunoglobulin
11/16/1999US5985598 TCL-1 gene and protein and related methods and compositions
11/16/1999US5985597 DNA encoding prostaglandin receptor EP1
11/16/1999US5985588 Phagemid for antibody screening
11/16/1999US5985586 Methods for identifying compounds that modulate the activity of human N-methyl-D-aspartate receptors
11/16/1999US5985585 Competitive binding; detection
11/16/1999US5985583 Hybridization; measurement signal transduction
11/16/1999US5985580 Antibodies which specifically bind to the thymokine lymphotactin
11/16/1999US5985578 Autoantibodies and their targets in the diagnosis of peripheral neuropathies
11/16/1999US5985577 Detection od polypeptide segment in living cells
11/16/1999US5985574 Modulators of actin
11/16/1999US5985564 Inhibitor of chromosome segregation
11/16/1999US5985563 Detection of Ribosomal RNA using PNA probes
11/16/1999US5985553 erbB-2 gene segments, probes, recombinant DNA and kits for detection
11/16/1999US5985552 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
11/16/1999US5985547 Detection of a mutation in the HLA-DMβ gene in an immunocompromised patient
11/16/1999US5985546 Forming culture product; cytopathic effect
11/16/1999US5985541 Purified polypeptide; quantitative analysis
11/16/1999US5985351 Genetic engineering cassette of nucleic acid encoding wheat glutenin polypeptide; gene expression
11/16/1999US5985334 Contacting test compound to receptor from rat brain tissue that binds 6-acetyl-4-benzamido-3-hydroxy-2,2-dimethylbenzopyran derivatives
11/16/1999US5985332 Hemoglobins provided with ligands protecting the oxygen binding sites for use as artificial oxygen carriers for direct application in medicine and biology, and method for the preparation thereof
11/16/1999US5985288 Outer membrane protein P1 and peptides of Haemophilus influenzae type B
11/16/1999US5985287 Compounds and methods for treatment and diagnosis of mycobacterial infections
11/16/1999US5985286 Adenyl cyclase-hemolysin (ac-hly) protein,
11/16/1999US5985285 Vaccines for plague
11/16/1999US5985283 Adenovirus E1A-Associated protein BS69, inhibitor of E1A-transactivation
11/16/1999US5985280 Diagnosis and/or therapy of tumours using monoclonal antibodies specific for the human IL-4 receptor
11/16/1999US5985279 Humanized antibody against CD18
11/16/1999US5985277 Useful for diagnosis and treatement of corynebacterium infections and diseases.
11/16/1999US5985275 β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection
11/16/1999US5985268 Gamma-irradiated bacterial preparation having anti-tumor activity
11/16/1999US5985267 Protein toxins active against lepidopteran pests
11/16/1999US5985265 Attaching a polyethylene glycol molecule to a consensus interferon molecule via reductive alkylation.
11/16/1999US5985263 Substantially pure histidine-linked protein polymer conjugates
1 ... 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 ... 2916